Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220614055172N1Phase 3Completed
Phase 3 trial of ondansetron and ginger in None, sponsored by Hamadan University of Medical Sciences. Primary endpoints: Nausea and vomiting incidence and/or severity, Shivering incidence and/or severity and 1 more. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220614055172N1.